Hectors, Stefanie J.
Gordic, Sonja
Semaan, Sahar
Bane, Octavia
Hirten, Robert
Jia, Xiaoyu
Colombel, Jean-Frederic
Taouli, Bachir
Funding for this research was provided by:
Guerbet LLC
Sanford J Grossman Charitable Trust for Integrative Studies in IBD at Mount Sinai
Article History
Received: 13 March 2018
Revised: 12 June 2018
Accepted: 21 June 2018
First Online: 17 July 2018
Compliance with ethical standards
:
: The scientific guarantor of this publication is Bachir Taouli, MD.
: The authors of this manuscript declare relationships with the following companies: Jean-Frederic Colombel is a consultant for AbbVie, Amgen, Boehringer-Ingelheim, Celgene Corporation, Celltrion, Enterome, Ferring, Genentech, Janssen and Janssen, Medimmune, Merck & Co., Pfizer, Protagonist, Second Genome, Seres, Shire, Takeda and Theradiag, a speaker for AbbVie, Ferring and Speaker’s bureau for Amgen and received grant support from AbbVie, Takeda and Janssen and Janssen. Bachir Taouli received grant support from Guerbet and Bayer.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: • prospective• observational• performed at one institution